Overview of the Advisory Council on the Misuse of Drugs' (ACMD) work from January 2020 to December 2022.
Advisory Council On The Misuse Of Drugs
- Press release: Local treasures in Wales to be saved and restored
- Press release: British soldiers successfully test drone killer radiowave weapon for first time
- Transparency data: Royal Courts of Justice Cause List
- Guidance: River Thames: current river conditions
- Transparency data: Small boat activity in the English Channel
- Press release: 10,000 UK Armed Forces personnel deployed overseas to keep us safe this Christmas
- Guidance: The white book for foreign service advisers and defence attachés
- Guidance: River Thames: current river conditions
- Transparency data: Small boat activity in the English Channel
- Bird flu (avian influenza): latest situation in England
Occupations, career history and interests of the members of the Advisory Council on the Misuse of Drugs (ACMD).
A review of the evidence on the use and harms of 2-benzyl benzimidazole (nitazene) and piperidine benzimidazolone (brorphine-like) opioids.
The Advisory Council on the Misuse of Drugs responds to the government on their proposal to amend the licensing regimen for industrial hemp.
Occupations, career history and interests of the members of the Advisory Council on the Misuse of Drugs (ACMD).
The Advisory Council on the Misuse of Drugs has provided an updated harms assessment of alkyl nitrites.
The Novel Psychoactive Substances Committee (NPSC) is seeking evidence for its review of the evidence of the misuse and harms of synthetic cathinones in the UK.
A review of the evidence on the use and harms of 2-benzyl benzimidazole (nitazene) and piperidine benzimidazolone (brorphine-like) opioids.
The Advisory Council on the Misuse of Drugs has provided an updated harms assessment of alkyl nitrites.
ACMD work programme 2024 letter to the Home Secretary from the Chair of the Advisory Council on the Misuse of Drugs (ACMD).
A review of the evidence on the use and harms of 2-benzyl benzimidazole (nitazene) and piperidine benzimidazolone (brorphine-like) opioids.
A review of the evidence on the use, harms and prevalence of recently encountered uncontrolled novel benzodiazepines and related compounds (2024 update).
A review of the evidence on the use, harms and prevalence of recently encountered uncontrolled novel benzodiazepines and related compounds (2024 update).
This report has considered the harms and control of 2-methyl-AP-237 and other closely related acyl piperazine opioids.
This report has considered the harms and control of 2-methyl-AP-237 and other closely related acyl piperazine opioids.
Government response to the third addendum to the Advisory Council on the Misuse of Drugs' report on 2-benzyl benzimidazole and piperidine benzimidazolone opioids.
Review of the evidence on the use and harms of xylazine, medetomidine and detomidine.
Review of the evidence on the use and harms of xylazine, medetomidine and detomidine.
Review of the evidence on the use and harms of xylazine, medetomidine and detomidine.
Review of the evidence on the use and harms of xylazine, medetomidine and detomidine.
ACMD work programme 2024 letter to the Home Secretary from the Chair of the Advisory Council on the Misuse of Drugs (ACMD).
Recommendations from the ACMD to reduce barriers to research for schedule 1 controlled drugs.
The Advisory Council on the Misuse of Drugs (ACMD) seeks to gather insight into current government-led drug prevention policies and landscape across the UK.
Recommendations from the ACMD to reduce barriers to research for schedule 1 controlled drugs.
The Advisory Council on the Misuse of Drugs call for evidence, collecting written evidence to better understand internet-facilitated drug markets (IFDMs).
A review of the evidence on the use and harms of 2-benzyl benzimidazole (nitazene) and piperidine benzimidazolone (brorphine-like) opioids.
Fifteen new synthetic opioids and 5 other drugs will be banned as Class A drugs as the government continues to act to prevent drug deaths.
The Advisory Council on the Misuse of Drugs call for evidence, collecting written evidence to better understand internet-facilitated drug markets (IFDMs).
Report from the Advisory Council on the Misuse of Drugs (ACMD) on consumer cannabidiol (CBD) products.
The government responds to a report by the Advisory Council on the Misuse of Drugs and commissions Part 2 of work on barriers to research.
A review of the evidence on the use and harms of 2-benzyl benzimidazole (nitazene) and piperidine benzimidazolone (brorphine-like) opioids.
A review of the evidence on the use and harms of 2-benzyl benzimidazole (nitazene) and piperidine benzimidazolone (brorphine-like) opioids.
The Advisory Council on the Misuse of Drugs has undertaken a review of the availability and implementation of naloxone in the UK.
The ACMD will use your response to help them formulate advice to government about drug use in ethnic minority groups.
The Advisory Council on the Misuse of Drugs (ACMD) has provided advice on the scheduling of nitrous oxide.
The Home Secretary has today announced the reappointment of Professor Owen Bowden-Jones as the chair of the ACMD.
Call for evidence from the Advisory Council on the Misuse of Drugs on the prevalence and drivers of powder cocaine use by young people and adults.
The Advisory Council on the Misuse of Drugs (ACMD) has provided advice on the scheduling of nitrous oxide.
The Home Office is looking for 16 new members to join the Advisory Council on the Misuse of Drugs (ACMD).
Letter commissioning the Advisory Council on the Misuse of Drugs (ACMD) to work on a project to prevent drug use in children and young people.
Call for evidence from the Advisory Council on the Misuse of Drugs on the prevalence and drivers of powder cocaine use by young people and adults.
Government response to the ACMD's review of the evidence on the use and harms of Cumyl-PeGaClone.
Government response to the ACMD's review of the evidence on the use and harms of Cumyl-PeGaClone.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) regarding electronic prescribing of controlled drugs proposal from NHS England.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) regarding electronic prescribing of controlled drugs proposal from NHS England.
Ministerial Departmental News
- PM's Office, 10 Downing Street
- Cabinet Office
- Department for Business, Innovation and Skills
- Department for Communities and Local Government
- Department for Culture, Media and Sport
- Department for Education
- Department for Environment, Food and Rural Affairs
- Department for International Development
- Department for Transport
- Department for Work and Pensions
- Department of Energy and Climate Change
- Department of Health
- Foreign and Commonwealth Office
- HM Treasury
- Home Office
- Ministry of Defence
- Ministry of Justice
- Northern Ireland Office
- Scotland Office
- Wales Office
- See all departments